Skip to content

SCHEDULE 13D/AAccepted Jun 1, 9:31 PM ET

Outlook Therapeutics, Inc. SCHEDULE 13D/A

GMS Ventures & Investments

Accepted (ET)

9:31 PM

Jun 1, 2026

Filed

Jun 1, 2026

Documents

2

Size

22.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.